Volume | 374,331 |
|
|||||
News | - | ||||||
Day High | 29.82 | Low High |
|||||
Day Low | 28.90 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Harmony Biosciences Holdings Inc | HRMY | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
29.27 | 28.90 | 29.82 | 29.72 | 29.03 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
8,488 | 374,331 | $ 29.49 | $ 11,038,988 | - | 18.6112 - 39.265 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:30:49 | 2 | $ 30.65 | USD |
Harmony Biosciences Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.69B | 56.77M | - | 582.02M | 128.85M | 2.27 | 13.08 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Harmony Biosciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HRMY Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 30.43 | 31.32 | 28.8701 | 29.59 | 307,197 | -0.71 | -2.33% |
1 Month | 29.31 | 34.40 | 28.14 | 30.33 | 459,843 | 0.41 | 1.40% |
3 Months | 32.42 | 34.44 | 28.14 | 30.96 | 426,025 | -2.70 | -8.33% |
6 Months | 27.11 | 35.395 | 27.105 | 31.43 | 428,459 | 2.61 | 9.63% |
1 Year | 35.08 | 39.265 | 18.6112 | 30.93 | 532,060 | -5.36 | -15.28% |
3 Years | 31.15 | 62.085 | 18.6112 | 38.71 | 524,486 | -1.43 | -4.59% |
5 Years | 36.50 | 62.085 | 18.6112 | 38.47 | 453,699 | -6.78 | -18.58% |
Harmony Biosciences Description
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. |